Risk-Dependent Conditional Survival and Failure Hazard After Radiotherapy for Early-Stage Extranodal Natural Killer/T-Cell Lymphoma

Author:

Liu Xin1234,Wu Tao5,Zhu Su-Yu6,Shi Mei7,Su Hang8,Wang Ying9,He Xia10,Xu Li-Ming11,Yuan Zhi-Yong11,Zhang Li-Ling12,Wu Gang12,Qu Bao-Lin13,Qian Li-Ting14,Hou Xiao-Rong15,Zhang Fu-Quan15,Zhang Yu-Jing161718,Zhu Yuan19,Cao Jian-Zhong20,Lan Sheng-Min20,Wu Jun-Xin21,Qi Shu-Nan1234,Yang Yong1234,Li Ye-Xiong1234

Affiliation:

1. State Key Laboratory of Molecular Oncology, Beijing, People’s Republic of China

2. Department of Radiation Oncology, National Cancer Center and Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

3. Center for Cancer Precision Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

4. National Institute of Biological Sciences, Collaborative Innovation Center for Cancer Medicine, Beijing, People’s Republic of China

5. Affiliated Hospital of Guizhou Medical University, Guizhou Cancer Hospital, Guiyang, Guizhou, People’s Republic of China

6. Hunan Cancer Hospital and the Affiliated Cancer Hospital of Xiangya School of Medicine, Changsha, Hunan, People’s Republic of China

7. Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi, People’s Republic of China

8. 307 Hospital, Academy of Military Medical Science, Beijing, People’s Republic of China

9. Chongqing Cancer Hospital & Cancer Institute, Chongqing, People’s Republic of China

10. Jiangsu Cancer Hospital & Jiangsu Institute of Cancer Research, Nanjing, Jiangsu, People’s Republic of China

11. Tianjin Medical University Cancer Institute & Hospital, Key Laboratory of Cancer Prevention and Therapy, National Clinical Research Center for Cancer, Tianjin, People’s Republic of China

12. Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, People’s Republic of China

13. The General Hospital of Chinese People's Liberation Army, Beijing, People’s Republic of China

14. The Affiliated Provincial Hospital of Anhui Medical University, Hefei, Anhui, People’s Republic of China

15. Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, People’s Republic of China

16. Sun Yat-sen University Cancer Center, Guangzhou, Guangdong, People’s Republic of China

17. State Key Laboratory of Oncology in South China, Guangzhou, Guangdong, People’s Republic of China

18. Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, People’s Republic of China

19. Zhejiang Cancer Hospital, Hangzhou, Zhejiang, People’s Republic of China

20. Shanxi Cancer Hospital and the Affiliated Cancer Hospital of Shanxi Medical University, Taiyuan, Shanxi, People’s Republic of China

21. Fujian Provincial Cancer Hospital, Fuzhou, Fujian, People’s Republic of China

Publisher

American Medical Association (AMA)

Subject

General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3